Core Technology

ENERGI-F707  (Treatments of Mitochondria Difficiency)

With the aging of the Taiwanese society, cases of senior citizens contracting nerve-related diseases have been on the rise. Deficient function of mitochondria has been widely regarded to be closely associated with brain neurodegenerative disease, such as Alzheimer's disease and Parkinson's disease. As a cellular energy factory, mitochondria provides energy molecule ATP to meet various physiological and biochemical needs of cells. Energenesis Biomedical team discovered that ENERGI-F707 can increase the number of mitochondria in nerve microglia and cellular ATP via adjusting AMPK/PGC-alpha in cells. Judging from brain stem sections of second-type diabetic mice, it is evident that long-term feeding of ENERGI-F707 in conducive to improving the share of diabetic mice's nerve microglia.